Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
INVO Bioscience (INVO)
NASDAQ:INVO
INVO Bioscience (INVO) Stock Price & Analysis
118 Followers
INVO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.50 - $8.60
Previous Close$0.9
Volume64.54K
Average Volume (3M)3.88M
Market Cap
$3.42M
Enterprise Value$7.40M
Total Cash (Recent Filing)$112.48K
Total Debt (Recent Filing)$4.10M
Price to Earnings (P/E)―
Beta0.44
Next Earnings
Aug 12, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.98
Shares Outstanding3,808,752
10 Day Avg. Volume116,953
30 Day Avg. Volume3,884,753
Standard Deviation0.28
R-Squared0.08
Alpha-0.06
Financial Highlights & Ratios
Price to Book (P/B)-0.35
Price to Sales (P/S)12.28
Price to Cash Flow (P/CF)-0.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue6.95
Enterprise Value/Gross Profit13.83
Enterprise Value/Ebitda-1.89
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
INVO Bioscience News
PremiumCompany Announcements
INVO Bioscience Navigates Lease Assignment and Nasdaq Woes
PremiumCompany Announcements
INVO Bioscience Seeks Funds After NAYA Misses Deadline
Ownership Overview
43.04%
Insiders
2.16% Mutual Funds
1.91% Other Institutional Investors
52.89% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
INVO FAQ
What was INVO Bioscience’s price range in the past 12 months?
INVO Bioscience lowest stock price was $0.50 and its highest was $8.60 in the past 12 months.
What is INVO Bioscience’s market cap?
Currently, no data Available
When is INVO Bioscience’s upcoming earnings report date?
INVO Bioscience’s upcoming earnings report date is Aug 12, 2024 which is in 72 days.
How were INVO Bioscience’s earnings last quarter?
Currently, no data Available
Is INVO Bioscience overvalued?
According to Wall Street analysts INVO Bioscience’s price is currently Overvalued.
Does INVO Bioscience pay dividends?
INVO Bioscience does not currently pay dividends.
What is INVO Bioscience’s EPS estimate?
INVO Bioscience’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does INVO Bioscience have?
INVO Bioscience has 3,808,752 shares outstanding.
What happened to INVO Bioscience’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of INVO Bioscience?
Currently, no hedge funds are holding shares in INVO
---
INVO Bioscience Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-85.06%
12-Months-Change
Fundamentals
Return on Equity
-9999.00%
Trailing 12-Months
Asset Growth
197.79%
Trailing 12-Months
Company Description
INVO Bioscience
INVO BioScience, Inc. focuses on the creation of treatment options for patients diagnosed with infertility. It offers a patented medical device that is used for infertility treatment under the name INVOcell. The company was founded by Kathleen Karloff and Claude Ranoux on January 5, 2007 and is headquartered in Medford, MA.
---
INVO Earnings Call
Q2 2023
0:00 / 0:00
---
INVO Stock 12 Month Forecast
Average Price Target
―Technical Analysis
---